European drug regulators on Friday endorsed a new and simpler treatment for sleeping sickness, in what could be a giant boost to efforts to eliminate the disease.
A European Medicines Agency committee gave its nod to acoziborole, made by Sanofi. The decision is seen as a crucial step to making the medicine available in Congo, the country with the most sleeping sickness cases, and paving the way for its use in other African countries.
